2016 AAPM Annual Meeting
Back to session list

Session Title: Treatment Planning System Commissioning and QA
Question 1: The benefits of participating in a national or international incident learning system include:
Reference:ASTRO RO-ILS web site: https://www.astro.org/roils/ SAFRON web site: https://rpop.iaea.org/RPOP/RPoP/Modules/login/safron-register.htm ROSIS web site: http://www.rosis.info/index.php
Choice A:Promoting safety culture.
Choice B:Receiving Reports on incidents from a larger community.
Choice C:Analyzing local safety improvement efforts.
Choice D:Gaining access to safety related articles and teaching.
Choice E:All of the above
Question 2: The new MPPG 5 is intended to replace the old Task Group #53 report.
Reference:Fraass, B. et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med. Phys. 25, 1773–1829 (1998). Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015).
Choice A:True.
Choice B:False.
Question 3: What does the MPPG #5 recommend for gamma analysis criteria for IMRT/VMAT TPS validation?
Reference:Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015). Opp, D, B E Nelms, G Zhang, C Stevens, and V Feygelman. "Validation of measurement-guided 3D VMAT dose reconstruction on a heterogeneous anthropomorphic phantom." J. Appl. Clin. Med. Phys. 14, no. 4 (Jul 2013): 4154
Choice A:1%/1mm.
Choice B:2%/2 mm
Choice C:3%/3 mm
Choice D:5%/5 mm
Choice E:No recommendation is given. User should reference current accrediting criteria and published literature.
Question 4: The MPPG #5 recommends which of the following for IMRT/VMAT validation?
Reference:Smilowitz, J. B. et al. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of Treatment Planning Dose Calculations - Megavoltage Photon and Electron Beams. J. Appl. Clin. Med. Phys. 16, 14–34 (2015).
Choice A:Small PDD and OF measurements not used in commissioning.
Choice B:AAPM TG 119 tests.
Choice C:DQA on representative clinical IMRT/VMAT cases.
Choice D:External review.
Choice E:All of the above.
Question 5: The upcoming TG100 report predominantly relies on:
Reference:M.S. Huq, B.A. Fraass, P.B. Dunscombe, J.P. Gibbons, G.S. Ibbott, P.M. Medin, A. Mundt, S. Mutic, J.A. Palta, B.R. Thomadsen, J.F. Williamson, E.D. Yorke. A method for evaluating quality assurance needs in radiation therapy. Int J Radiat Oncol Biol Phys, 2008; 71(1 Suppl), S170-3.
Choice A:SPC
Choice B:ILS
Choice C:QC/QA
Choice D:FMEA
Choice E:RPC
Question 6: RPC tolerance for IMRT head and neck phantom irradiation is:
Reference:Molineu et al, Credentialing results from IMRT irradiations of an anthropomorphic head and neck, Med Phys, 40, 2013.
Choice A:2%/2mm
Choice B:3%/3mm
Choice C:7%/4mm
Choice D:2%
Choice E:2mm
Back to session list